Chronic central serous chorioretinopathy (cCSC): Differential diagnosis to choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD);Chronische RCS (chronic Central Serous Chorioretinopathy cCSC) als Differenzialdiagnose der feuchten, altersbedingten Makuladegeneration (AMD)

Klinische Monatsblatter fur Augenheilkunde

Volumn 229, Issue 9, 2012, Pages 889-896

  Inhoffen, W ^a   Ziemssen, F ^a   Bartz Schmidt, K U ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

age related macular degeneration (AMD); central serous chorioretinopathy (CSC); choroidal neovascularisation (CNV); indocyanine green angiography (ICG); optical coherence tomography (OCT); photodynamic therapy (PDT)

Indexed keywords

CORTICOSTEROID;

ARTICLE; AUTOFLUORESCENCE; CENTRAL SEROUS RETINOPATHY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; HUMAN; OPHTHALMOSCOPY; PHOTODYNAMIC THERAPY; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; UVEITIS;

ANGIOGENESIS INHIBITORS; CENTRAL SEROUS CHORIORETINOPATHY; CHOROIDAL NEOVASCULARIZATION; DIAGNOSIS, DIFFERENTIAL; HUMANS; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84866264488     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0032-1315077     Document Type: Article

References (31)

1. Wang M, Munch IC, Hasler PW et al. Central serous chorioretinopathy. Acta Ophthalmologica: 2008; 86 126 145
2. Baraki H, Feltgen N, Roider J et al. Chorioretinopathia centralis serosa (CCS). Ophthalmologe: 2010; 107 479 493
3. Kanyange ML, De Laey JJ. Long-term follow-up of central serous chorioretinopathy (CSCR). Bull Soc Belge Ophtalmol: 2002; 284 39 44
4. Petriconi ECR. Chorioretinopathia centralis serosa (CCS): Klinisch-angiographische Befunde und Risikofaktoren [Dissertation]. Ulm Universitäts Augenklinik Ulm: 2007; 1 81
5. Brancato R, Scialdone A, Pece A et al. Eight-year follow-up of central serous chorioretinopathy with and without laser treatment. Graefes Arch Clin Exp Ophthalmol: 1987; 225 166 168
6. Castro-Correia J, Coutinho MF, Rosas V et al. Long-term follow-up of central serous retinopathy in 150 patients. Doc Ophthalmol: 1992; 81 379 386
7. Wang M, Sander B, la Cour M et al. Clinical characteristics of subretinal deposits in central serous chorioretinopathy. Acta Ophthalmol Scand: 2005; 83 691 696
8. Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond): 2010; 24 1743 1756
9. Piccolino FC, Eandi CM, Ventre L et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina: 2003; 23 752 763
10. Inoue R, Sawa M, Tsujikawa M et al. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol: 2010; 149 441 446
11. Gupta P, Gupta V, Dogra MR et al. Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol: 2010; 30 175 181
12. Framme C, Walter A, Gabler B et al. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy. Acta Ophthalmol Scand: 2005; 83 161 167
13. Eandi CM, Ober M, Iranmanesh R et al. Acute central serous chorioretinopathy and fundus autofluorescence. Retina: 2005; 25 989 993
14. Oota S, Hangai M, Sakamoto A et al. High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy. Ophthalmology: 2010; 117 1800 1809
15. Ojima Y, Tsujikawa A, Hangai M et al. Retinal sensitivity measured with the micro perimeter 1 after resolution of central serous chorioretinopathy. Am J Ophthalmol: 2008; 146 77 84
16. Reibaldi M, Boscia F, Avitabile T et al. Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol: 2011; 151 953 960
17. Maier M, Valet V, Feucht N et al. Chorioretinopathia centralis serosa. Teil 1: Epidemiologie, Symptome, Diagnostik, Verlauf. Z prakt Augenheilkd: 2011; 32 139 146
18. Maruko I, Iida T, Sugano Y et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology: 2010; 117 1792 1799
19. Spaide R. Autofluorescence from the outer retina and subretinal space. Hypothesis and review. Retina: 2008; 28 5 35
20. Yannuzzi LA. Central serous Chorioretinopathy. In: Yannuzzi LA. Hrsg. The retinal Atlas. Kapital 10. Saunders: 2010; 762 777
21. Yannuzzi LA, Freund KB, Goldbaum M et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology: 2000; 107 767 777
22. Lim JW, Kang SW, Kim YT et al. Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy. Br J Ophthalmol: 2011; 95 514 517
23. Chan WM, Lam DS, Lai TY et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol: 2003; 87 1453 1458
24. Yannuzzi LA, Slakter JS, Gross NE et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina: 2003; 23 288 298
25. Chan WM, Lai TYY, Lai RYK et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy. One-year results of a randomized controlled trial. Ophthalmology: 2008; 115 1756 1765
26. Reibaldi M, Cardascia N, Longo A et al. Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. Am J Ophthalmol: 2010; 149 307 315
27. Senturk F, Karacorlu M, Ozdemir H et al. Micropermetric changes after photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol: 2011; 151 303 309
28. Maier M, Valet V, Feucht N et al. Chorioretinopathia centralis serosa. Teil 2: Therapie. Z prakt Augenheilkd: 2011; 32 181 190
29. Lim SJ, Roh MI, Kwon OW et al. Intravitreal bevacizumab injection for central serous chorioretinopathy. Retina: 2010; 30 100 106
30. Arevalo JF, Espinozy JV. Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up. Graefes Arch Clin Exp Ophthalmol: 2011; 249 1159 1166
31. Agarwal A. Diseases causing exudative and hemorrhagic Detachment: idiopathic central serous Chorioretinopathy. In Agarwal A. Hrsg. Gass Atlas of Macular Diseases. 5th ed., chapter 3. Elsevier: 2010; 66 91